Breast Pathology

Masters of Pathology Series

Improve patient outcomes with this CME program detailing the latest advancements and emerging issues in Breast Pathology. Earn Lifelong Learning and SAM credits. Scheduled for release December 31, 2018.

If your primary viewing mode will be on a computer or tablet, we recommend the Online Video package. In addition to online access, you will receive a USB with MP4 files. Use the USB to watch offline or import into iTunes and other media players and then synch to your mobile device, laptop or desktop. Plus you save $130 including standard shipping charges vs the DVD package.

    Video
795.0000
SKU: 289

Stay Current in a Rapidly Changing Field

This CME program, featuring experts in the practice of Breast Pathology, is a comprehensive review of the core concepts and emerging trends in the field. Masters of Pathology SeriesBreast Pathology covers updates on ER/PR/HER2 testing, contemporary issues in core needle biopsy, deceptive patterns and mimics of invasive breast cancer, and more. It will help you to better:

  • Evaluate diagnostic criteria and clinical significance of common and uncommon benign, in situ, and malignant lesions
  • Address differential diagnostic problems commonly encountered in breast pathology
  • Gain the latest information on the uses and limitations of IHC in diagnostic breast pathology
  • Understand the latest guidelines for ER, PR and HER2 testing and reporting

Expand Your Skills

Available online, Masters of Pathology SeriesBreast Pathology provides a maximum of 13.5 AMA PRA Category 1 Credits and access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

Quick Facts

Provider: Oakstone

Course Directors:
Laura C. Collins, MD
Professor of Pathology
Harvard Medical School
Vice Chair of Anatomic Pathology
Director of Breast Pathology
Department of Pathology
Beth Israel Deaconess Medical Center
Boston, MA

Melinda J. Lerwill, MD
Assistant Professor of Pathology
Harvard Medical School
Associate Pathologist
Director of Breast Pathology
Massachusetts General Hospital
Boston, MA

Credits: Earn a maximum of 13.5 AMA PRA Category 1 Credits

  • Atypical Ductal Proliferations - Melinda J. Lerwill, MD
  • Lobular Carcinoma in Situ; Classical and Non-classical Forms - Laura C. Collins, MD
  • Ductal Carcinoma in Situ: Diagnostic Evaluation and Problematic Patterns - Melinda J. Lerwill, MD
  • Papillary Lesions - Laura C. Collins, MD
  • Fibroepithelial Neoplasms - Melinda J. Lerwill, MD
  • Mucinous Lesions - Laura C. Collins, MD
  • Specimen Handling, Margin Evaluation and Reporting - Melinda J. Lerwill, MD
  • Current Issues for Core Needle Biopsy of the Breast - Laura C. Collins, MD
  • Evaluation of Cancers Treated with Neoadjuvant Systemic Therapy - Melinda J. Lerwill, MD
  • ER/PR/HER2 Testing-Updates - Laura C. Collins, MD
  • Spindle Cell Lesions - Melinda J. Lerwill, MD
  • Special Types of Invasive Breast Cancers - Laura C. Collins, MD
  • Deceptive Patterns and Mimics of Invasive Breast Cancer - Melinda J. Lerwill, MD
  • Newer Prognostic and Predictive Factors - Laura C. Collins, MD
  • Nipple Lesions - Laura C. Collins, MD
  • Vascular Lesions - Melinda J. Lerwill, MD

Course Directors

Laura C. Collins, MD

  • Professor of Pathology
  • Harvard Medical School
  • Vice Chair of Anatomic Pathology
  • Director of Breast Pathology
  • Department of Pathology
  • Beth Israel Deaconess Medical Center
  • Boston, MA

 

Melinda J. Lerwill, MD

  • Assistant Professor of Pathology
  • Harvard Medical School
  • Associate Pathologist
  • Director of Breast Pathology
  • Massachusetts General Hospital
  • Boston, MA

Accreditation Statement

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing, LLC designates this enduring material for a maximum of 13.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: December 31, 2018
Date Credits Expire:December 31, 2021

CME credit is awarded upon successful completion of a course evaluation and post-test.

Masters of Pathology Series — Breast Pathology has been registered as a Lifelong Learning (Part II) and Self-Assessment Module (SAM) to offer credits in the American Board of Pathology's (ABPath) Continuing Certification program.

Learning Objectives

At the conclusion of this CME activity, the participant will be able to:

  • Evaluate diagnostic criteria and clinical significance of various common and uncommon benign, in situ and malignant lesions of the breast in both core needle biopsy specimens and surgical specimens
  • Describe differential diagnostic problems commonly encountered in breast pathology and develop strategies to resolve them in the practice environment
  • Utilize the latest information on the uses and limitations of immunohistochemistry in resolving diagnostic problems in breast pathology
  • Understand the updated guidelines for ER, PR and HER2 testing and reporting

Intended Audience

This educational activity was designed for practicing pathologists, and residents including forensic pathologists.